Thus, CSF3R truncating and activating mutations may co-occur in SCN similarly to CNL, but while activating CSF3R mutations are present in the vast majority of CNL patients with a minority co-carrying truncation mutants, truncating CSF3R mutations prevail in SCN [18]. This evidence concerns the gene CSF3R and chronic neutrophilic leukemia.